Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Pandemic Influenza Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period.
This report presents the market size and development trends by detailing the Pandemic Influenza Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pandemic Influenza Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pandemic Influenza Vaccine industry and will help you to build a panoramic view of the industrial development.
Pandemic Influenza Vaccine Market, By Type:
Influenza A (H1N1) Vaccines
Other
Pandemic Influenza Vaccine Market, By Application:
Adult
Paediatric
Some of the leading players are as follows:
AstraZeneca
Novartis
Valneva
Solvay and Serum Institute of India Pvt Ltd
Sanofi
Chiron Panacea
GlaxoSmithKline
Lupin
Solvay and Serum Institute of India Pvt. Ltd.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Pandemic Influenza Vaccine Market: Technology Type Analysis
-
4.1 Pandemic Influenza Vaccine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Pandemic Influenza Vaccine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Influenza A (H1N1) Vaccines
4.3.2 Other
5 Pandemic Influenza Vaccine Market: Product Analysis
-
5.1 Pandemic Influenza Vaccine Product Market Share Analysis, 2018 & 2026
-
5.2 Pandemic Influenza Vaccine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Pandemic Influenza Vaccine Market: Application Analysis
-
6.1 Pandemic Influenza Vaccine Application Market Share Analysis, 2018 & 2026
-
6.2 Pandemic Influenza Vaccine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Adult
6.3.2 Paediatric
7 Pandemic Influenza Vaccine Market: Regional Analysis
-
7.1 Pandemic Influenza Vaccine Regional Market Share Analysis, 2018 & 2026
-
7.2 Pandemic Influenza Vaccine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 AstraZeneca
9.1.1 AstraZeneca Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Novartis
9.2.1 Novartis Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Valneva
9.3.1 Valneva Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Solvay and Serum Institute of India Pvt Ltd
9.4.1 Solvay and Serum Institute of India Pvt Ltd Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Sanofi
9.5.1 Sanofi Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Chiron Panacea
9.6.1 Chiron Panacea Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 GlaxoSmithKline
9.7.1 GlaxoSmithKline Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Lupin
9.8.1 Lupin Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Solvay and Serum Institute of India Pvt. Ltd.
9.9.1 Solvay and Serum Institute of India Pvt. Ltd. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
The List of Tables and Figures (Totals 66 Figures and 138 Tables)
Figure Influenza A (H1N1) Vaccines Pandemic Influenza Vaccine market, 2015 - 2026 (USD Million)
Figure Other Pandemic Influenza Vaccine market, 2015 - 2026 (USD Million)
Figure Adult market, 2015 - 2026 (USD Million)
Figure Paediatric market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Pandemic Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table North America Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table North America Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table North America Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Pandemic Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table France Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table France Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pandemic Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table China Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table China Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table India Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table India Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Pandemic Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Pandemic Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Pandemic Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Pandemic Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Pandemic Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Valneva Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Solvay and Serum Institute of India Pvt Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Chiron Panacea Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lupin Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Solvay and Serum Institute of India Pvt. Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
